DI MARINO, PIETRO
 Distribuzione geografica
Continente #
EU - Europa 173
NA - Nord America 172
AS - Asia 79
SA - Sud America 1
Totale 425
Nazione #
US - Stati Uniti d'America 171
IT - Italia 79
SG - Singapore 63
IE - Irlanda 50
SE - Svezia 14
DE - Germania 7
CZ - Repubblica Ceca 6
RU - Federazione Russa 6
CN - Cina 5
FI - Finlandia 3
HK - Hong Kong 3
IN - India 3
FR - Francia 2
GR - Grecia 2
JP - Giappone 2
UA - Ucraina 2
VN - Vietnam 2
BE - Belgio 1
CA - Canada 1
NL - Olanda 1
PY - Paraguay 1
TR - Turchia 1
Totale 425
Città #
Singapore 58
Dublin 50
Chandler 40
Chieti 22
Ashburn 17
Santa Clara 11
Pescara 10
Milan 8
New York 8
Boardman 6
Munich 6
Ann Arbor 5
Corridonia 5
Los Angeles 5
Rome 5
Brno 4
Jacksonville 4
Princeton 4
Ascoli Piceno 3
Lanciano 3
Pune 3
Altamura 2
Athens 2
Bari 2
Dong Ket 2
Hong Kong 2
Karasawa 2
Klausen 2
Lappeenranta 2
L’Aquila 2
Olomouc 2
Washington 2
Amsterdam 1
Asunción 1
Beijing 1
Brussels 1
Elice 1
Fort Collins 1
Helsinki 1
Houston 1
Izmir 1
Jiaxing 1
Louisville 1
Moscow 1
Nanchang 1
Norwalk 1
Ottawa 1
Romola 1
Rozzano 1
Seattle 1
Stockholm 1
Treviso 1
Wilmington 1
Xi'an 1
Totale 321
Nome #
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 86
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 55
POLE exonuclease domain mutations in endometrial carcinoma: a case report 54
Tgf-β1 transcriptionally promotes 90K expression: possible implications for cancer progression 51
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 44
Prognostic value of gender and primary tumor location in metastatic colon cancer 39
Pancytopenia During Osimertinib Treatment in a Patient with EGFR-Mutated Non-Small Cell Lung Cancer 30
P1.09 Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC 26
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case report 25
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 21
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 18
From cachexia to obesity: the role of host metabolism in cancer immunotherapy 15
Totale 464
Categoria #
all - tutte 3.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.057


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 1 0 1 2 4 0 1 1
2020/202115 0 0 6 0 2 1 1 0 0 2 1 2
2021/202216 0 0 0 0 0 5 4 0 1 0 1 5
2022/2023112 4 7 13 10 13 20 4 15 14 0 8 4
2023/2024165 6 5 7 23 9 44 26 8 8 5 1 23
2024/2025138 14 57 52 13 2 0 0 0 0 0 0 0
Totale 464